The PROPHY-VAP Trial: Ceftriaxone to Prevent VAP in Patients with Acute Brain Injury
REBEL EM
FEBRUARY 29, 2024
Medication prepared by nurses in another unit not involved in the patients’ care. Patient data anonymized when presented to adjudication committee to avoid detection bias Well-balanced patient characteristics between groups. DOI: 10.1016/s2213-2600(23)00471-x From NLM. Critical Care 2014 , 18 (2), 208.
124 
Let's personalize your content